Global Tuberculosis:Developing,Evaluating,Implementing Evidence-based and Innovative Approaches to Find, Cure, and Prevent Tuberculosis Globally (93.494)
Global Tuberculosis:Developing,Evaluating,Implementing Evidence-based and Innovative Approaches to Find, Cure, and Prevent Tuberculosis Globally (Assistance Listing 93.494) is run by the Centers for Disease Control and Prevention, part of the Department of Health and Human Services. It awarded $18.4 million in 14 grants from fiscal 2021 to 2025, about $1.3 million per award on average. No funding opportunity is open on Grants.gov right now.
The typical award was $725,000. Half of the 14 awards fell between $262,500 and $1.3 million, and they ranged from $60,000 to $5.3 million.
- Awarded, FY 2021 to 2025$18.4 million
- Grant awards14
- Typical award$725,000
- Awarded in FY 2025$7.1 million
- Size rank1,337 of 1,823
- Type of assistanceCooperative agreement
Key findings
- Annual funding rose from $1.0 million in fiscal 2021 to $7.1 million in fiscal 2025.
- It is the 1337th largest of 1,823 federal grant programs by five-year awards.
- The 14 largest recipients received 100% of the money.
- Awards went to recipients in 5 states and territories.
What the program funds
CDC’s global health priorities include efforts towards ending the global tuberculosis (TB) epidemic by: expanding access to improved screening, contact tracing, and diagnostic tools to find the missing TB cases (FIND); optimizing treatment for TB and multi-drug-resistant (MDR) TB, including identifying and evaluating better treatment regimens, and expanding access to care and treatment (CURE); breaking the cycle of TB transmission by strengthening infection control, identifying TB hotspots to target screening, and scaling-up treatment to prevent TB (PREVENT); and helping countries strengthen their surveillance and laboratory systems, and workforce and research capacity to support sustainable health systems including promoting the wider use and adoption of recommended TB strategies and guidelines (SUSTAIN).
Open opportunities
No opportunity under this program is open or forecast on Grants.gov right now. Programs often post once a year, so the funding history below shows what to expect.
Rules from the program listing
Who can apply
Competition is open, limited, or single eligibility by authorizing legislation.
What the money can and cannot pay for
Uses and Restrictions are specified in individual Notice of Funding Opportunities. Funds may be spent for reasonable program purposes, including personnel, travel, operating costs including supplies, fuel for transportation, utilities, staff training costs including registration fees and purchase and rental of training related equipment, and purchase of reagents, test kits and laboratory equipment for Tuberculosis (TB) testing and services. Equipment may be purchased if deemed necessary to accomplish program objectives; however, prior approval by CDC officials must be requested in writing. All requests for funds contained in the budget shall be stated in U.S. dollars. Once an award is made, CDC will not compensate foreign grantees for currency exchange fluctuations through the issuance of supplemental awards. The costs that are generally allowable in grants to domestic organizations are allowable to foreign institutions and international organizations, with the following exception: With the exception of the American University, Beirut, and the World Health Organization (WHO), Indirect Costs will not be paid (either directly or through sub-award) to organizations located outside the territorial limits of the United States or to international organizations regardless of their location.
Matching requirements
This program has no statutory formula. Matching requirements are not applicable to this assistance listing. MOE requirements are not applicable to this assistance listing.
Award range and average, in the agency's words
Awards may range from $700,000 to $3,500,000. Average award is expected at $2,491,622.
Funding history and past recipients
From fiscal 2021 to 2025, Global Tuberculosis:Developing,Evaluating,Implementing Evidence-based and Innovative Approaches to Find, Cure, and Prevent Tuberculosis Globally (93.494) awarded $18.4 million across 14 grant awards, an average of $1.3 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Baylor College of Medicine | Texas | 1 | $5.3 million |
| United Nations Office for Project Services | 1 | $4.2 million | |
| Path | Washington | 1 | $2.7 million |
| World Health Organization, Somalia | 1 | $1.3 million | |
| Union Internat Tuberculose Maladie Respi | 1 | $1.3 million | |
| Ird VN Social Enterprise Company Limited | 1 | $1.0 million | |
| Society for Health Allied Research and Education India (Share India) | 1 | $750,000 | |
| Vietnam National Lung Hospital | 1 | $700,000 | |
| Georgetown University | District of Columbia | 1 | $400,000 |
| The Task Force for Global Health, Inc. | Georgia | 1 | $300,000 |
| African Field Epidemiology Network LTD | 1 | $250,000 | |
| The Aurum Institute NPC | 1 | $119,679 | |
| Association of Public Health Laboratories, Inc. (the) | Maryland | 1 | $100,000 |
| Vietnam Administration for Medical Services, Moh | 1 | $60,000 |
Who usually wins
Colleges and universities received 31% of the money, nonprofits 30%.
| Recipient type | Awards | Amount | Share |
|---|---|---|---|
| Other | 6 | $7.2 million | 39% |
| Colleges and universities | 2 | $5.7 million | 31% |
| Nonprofits | 6 | $5.5 million | 30% |
By state
2 states have a page for this program: those that received at least $1 million or 10 awards. They are Texas and Washington.
| State | Awards | Amount |
|---|---|---|
| Texas | 1 | $5.3 million |
| Washington | 1 | $2.7 million |
| District of Columbia | 1 | $400,000 |
| Georgia | 1 | $300,000 |
| Maryland | 1 | $100,000 |